Citigroup’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-103,820
Closed -$745K 5828
2023
Q1
$745K Buy
103,820
+102,452
+7,489% +$795K ﹤0.01% 2797
2022
Q4
$11.2K Buy
1,368
+104
+8% +$970 ﹤0.01% 4803
2022
Q3
$13K Sell
1,264
-9,654
-88% -$103K ﹤0.01% 4918
2022
Q2
$100K Buy
10,918
+8,607
+372% +$70.4K ﹤0.01% 4228
2022
Q1
$16K Sell
2,311
-86
-4% -$554 ﹤0.01% 5295
2021
Q4
$19K Buy
+2,397
New +$15.9K ﹤0.01% 5404

Other funds holding BLU

Citigroup's BLU Position: Q2 2023 in Review

Citigroup sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 103,820 shares — an estimated $745K sold.

Citigroup first reported a position in BLU in Q4 2021 and held it in 6 quarters. The position peaked at $745K in Q1 2023. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Citigroup reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Citigroup sold 103,820 BELLUS Health Inc. shares in Q2 2023, an estimated $745K.
  • Citigroup first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 6 quarters.
  • Citigroup's BELLUS Health Inc. position peaked at $745K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.